
Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…

Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…
Founded: 2023
Headquarters: Villejuif, Île-de-France, France
Focus: AI-powered precision oncology platform for drug development
Flagship products: O-Predict; O-Validate
Notable funding: Seed round (Dec 2024); ~€11M–€15M total raised
28 employees
Cancer drug development, with an emphasis on colorectal and pancreatic cancers
2023
Biotechnology Research
≈€11,000,000
Seed round announced Dec 3, 2024; reporting cites nondilutive support from Bpifrance and total capital raised to date near €15M in some sources.
“Bpifrance; Singular; additional investors recorded (Amazon Web Services, HCVC, SistaFund, Speedinvest, Verve Ventures)”
At Orakl Oncology , we are accelerating the development of oncology treatments. Today, fewer than 5% of new cancer drugs succeed in clinical trials. Clearly, new methods are needed. We combine cutting-edge biology and AI to build the next generation of insight platforms with the world’s largest cohort of patient tumor avatars. These avatars fuel our AI-powered predictive engine , helping to anticipate clinical trial outcomes, validate therapies, and uncover new drug candidates. By generating multimodal, real-world data, we deliver insights that consistently outperform existing solutions.
Our mission is simple yet ambitious: to who need them - and to make drug development smarter, faster, and more personalized. We collaborate with top hospitals, research institutes, and pharmaceutical companies worldwide. Backed by leading investors, we are a at the intersection of science and technology.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week
| Company |
|---|
Orakl’s develops a rapidly scaling operational platform that cultures, expands, freezes, and screens hundreds of patient-derived organoids (PDOs). As a Platform Engineering Intern , you will work hand-in-hand with the Orakl Oncology CTO on problems that sit at the heart of the company’s execution: designing, modeling, and optimizing the systems that govern how organoids move through the organization.
You will take ownership of analyzing Orakl’s end-to-end organoid operations as a production system—identifying bottlenecks, defining performance metrics, and translating biological workflows into quantitative, optimizable processes . Your work will directly inform how capacity is planned, how resources are allocated, and how the platform scales reliably as demand increases.
You will address high-impact operational questions with real constraints: how to optimize duplication and expansion strategies under limited lab capacity; how to model the optimal number of organoid lines to thaw, expand, or freeze at any given time; how to integrate stochastic arrivals of fresh patient samples into deterministic planning; how to increase weekly screening throughput without sacrificing data quality; and how to maintain rigorous traceability while minimizing operational overhead. You will collaborate closely with wet-lab operators, operations planners, and data scientists, turning analysis into deployable process changes.
Your Missions
We are looking for a curious, dynamic, creative and rigorous intern to join us. There is no formal training for the job we’re offering : it’s new. We imagine that candidates will be scientists interested in industry, engineers curious about biology labs, business students with a passion for the life sciences, or anybody else interested in scaling lab operations.
Needs to Have
Nice-to-Haves
HR Call (15 minutes call) – An initial discussion to better understand your background, experiences, and motivations.
Technical Interview (45 minutes call) – A deep dive into your technical skills and expertise relevant to the role.
Founder Interview: As final step of our recruitment process, you will meet the founders of Orakl Oncology in person at our office. This meeting is an opportunity for the founders to assess cultural fit and ensure alignment with our company values.